No letup in M&A, says Shire's Ornskov
This article was originally published in Scrip
Executive Summary
"When you run out of innovation, efficiency-driven M&A is always attractive," according to Shire CEO Dr Fleming Ornskov, speaking at the annual FT Global Pharmaceuticals and Biotechnology Conference in London(17-18 November) on what is driving the M&A hoopla of 2014. A subtle swipe at former suitor AbbVie?